FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890830469> ?p ?o ?g. }

• W2890830469 endingPage "1037" @default.
• W2890830469 startingPage "1019" @default.
• W2890830469 abstract "Antiestrogens (AEs) are widely used for treatment of estrogen receptor alpha (ERα)-positive breast cancer, but display variable degrees of partial agonism in estrogen target tissues and breast cancer (BC) cells. The fact that BC cells resistant to selective ER modulators (SERMs) like tamoxifen (Tam) can still be sensitive to pure AEs, also called selective ER downregulators, suggests different mechanisms of action, some of which may contribute to the more complete suppression of estrogen target genes by pure AEs. We report herein that pure AEs such as fulvestrant induce transient binding of ERα to DNA, followed by rapid release after 30–40 min without loss of nuclear localization. Loss of DNA binding preceded receptor degradation and was not prevented by proteasome inhibition. Chromatin was less accessible in the presence of fulvestrant than with estradiol or Tam as early as 20 min following treatment, suggesting that chromatin remodeling by pure AEs at ERα target regions prevents transcription in spite of receptor binding. SUMO2/3 marks were detected on chromatin at the peak of ERα binding in cells treated with pure AEs, but not SERMs. Furthermore, decreasing SUMOylation by overexpressing the deSUMOylase SENP1 significantly delayed receptor release from DNA and de-repressed expression of estrogen target genes in the presence of fulvestrant, both in ERα-expressing MCF-7 cells and in transiently transfected ER-negative SK-BR-3 cells. Finally, mutation V534E, identified in a breast metastasis resistant to hormonal therapies, prevented ERα modification and resulted in increased transcriptional activity of estrogen target genes in the presence of fulvestrant in SK-BR-3 cells. Together, our results establish a role for SUMOylation in achieving a more complete transcriptional shut-off of estrogen target genes by pure AEs vs. SERMs in BC cells." @default.
• W2890830469 created "2018-09-27" @default.
• W2890830469 creator A5019903925 @default.
• W2890830469 creator A5044933277 @default.
• W2890830469 creator A5063813876 @default.
• W2890830469 creator A5067257359 @default.
• W2890830469 creator A5090546289 @default.
• W2890830469 date "2018-09-06" @default.
• W2890830469 modified "2023-10-16" @default.
• W2890830469 title "Role of SUMOylation in differential ERα transcriptional repression by tamoxifen and fulvestrant in breast cancer cells" @default.
• W2890830469 cites W1491569850 @default.
• W2890830469 cites W1964527861 @default.
• W2890830469 cites W1964675354 @default.
• W2890830469 cites W1965093348 @default.
• W2890830469 cites W1975402264 @default.
• W2890830469 cites W1975658312 @default.
• W2890830469 cites W1975704872 @default.
• W2890830469 cites W1978806306 @default.
• W2890830469 cites W1981700185 @default.
• W2890830469 cites W2002262418 @default.
• W2890830469 cites W2005353027 @default.
• W2890830469 cites W2005702576 @default.
• W2890830469 cites W2013108773 @default.
• W2890830469 cites W2013809140 @default.
• W2890830469 cites W2018823550 @default.
• W2890830469 cites W2019311111 @default.
• W2890830469 cites W2021145743 @default.
• W2890830469 cites W2022743602 @default.
• W2890830469 cites W2023115583 @default.
• W2890830469 cites W2024044717 @default.
• W2890830469 cites W2033904805 @default.
• W2890830469 cites W2038208040 @default.
• W2890830469 cites W2039576757 @default.
• W2890830469 cites W2045389096 @default.
• W2890830469 cites W2054564508 @default.
• W2890830469 cites W2056155028 @default.
• W2890830469 cites W2060817283 @default.
• W2890830469 cites W2067184505 @default.
• W2890830469 cites W2067980525 @default.
• W2890830469 cites W2073367400 @default.
• W2890830469 cites W2078362264 @default.
• W2890830469 cites W2080174206 @default.
• W2890830469 cites W2090629961 @default.
• W2890830469 cites W2100768871 @default.
• W2890830469 cites W2111920523 @default.
• W2890830469 cites W2116705706 @default.
• W2890830469 cites W2117089877 @default.
• W2890830469 cites W2122969246 @default.
• W2890830469 cites W2130345393 @default.
• W2890830469 cites W2131663344 @default.
• W2890830469 cites W2133667885 @default.
• W2890830469 cites W2134427809 @default.
• W2890830469 cites W2138373011 @default.
• W2890830469 cites W2139726760 @default.
• W2890830469 cites W2146505166 @default.
• W2890830469 cites W2147673480 @default.
• W2890830469 cites W2147789776 @default.
• W2890830469 cites W2149475194 @default.
• W2890830469 cites W2160384550 @default.
• W2890830469 cites W2160587188 @default.
• W2890830469 cites W2207375898 @default.
• W2890830469 cites W2286629281 @default.
• W2890830469 cites W2323326409 @default.
• W2890830469 cites W2411335118 @default.
• W2890830469 cites W2511615467 @default.
• W2890830469 cites W2530784802 @default.
• W2890830469 cites W2538138106 @default.
• W2890830469 cites W2554965207 @default.
• W2890830469 cites W2567553314 @default.
• W2890830469 cites W2610419583 @default.
• W2890830469 cites W2620721366 @default.
• W2890830469 cites W2099296044 @default.
• W2890830469 doi "https://doi.org/10.1038/s41388-018-0468-9" @default.
• W2890830469 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6514857" @default.
• W2890830469 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30190545" @default.
• W2890830469 hasPublicationYear "2018" @default.
• W2890830469 type Work @default.
• W2890830469 sameAs 2890830469 @default.
• W2890830469 citedByCount "26" @default.
• W2890830469 countsByYear W28908304692019 @default.
• W2890830469 countsByYear W28908304692020 @default.
• W2890830469 countsByYear W28908304692021 @default.
• W2890830469 countsByYear W28908304692022 @default.
• W2890830469 countsByYear W28908304692023 @default.
• W2890830469 crossrefType "journal-article" @default.
• W2890830469 hasAuthorship W2890830469A5019903925 @default.
• W2890830469 hasAuthorship W2890830469A5044933277 @default.
• W2890830469 hasAuthorship W2890830469A5063813876 @default.
• W2890830469 hasAuthorship W2890830469A5067257359 @default.
• W2890830469 hasAuthorship W2890830469A5090546289 @default.
• W2890830469 hasBestOaLocation W28908304691 @default.
• W2890830469 hasConcept C104317684 @default.
• W2890830469 hasConcept C121608353 @default.
• W2890830469 hasConcept C126322002 @default.
• W2890830469 hasConcept C150194340 @default.
• W2890830469 hasConcept C171350616 @default.
• W2890830469 hasConcept C186310378 @default.
• W2890830469 hasConcept C25602115 @default.

• next